Clinical and immunological features of nasopharynx chronic pathology and immunotherapy in frequently ill children
A clinical and immunological study of 68 frequent ill and 30 healthy children before and after immunocorrect treatment was conducted. Reduction in both cellular and humoral immunity in patients average of 1.6 times compared to healthy children was shown. After a combined treatment with an immunomodulator IRS19, improvement in these indicators is noted. Based on immunological, inflammatory signs persist for longer than the clinical symptoms.